Description
The authors identify NF-κB as a possible pathway underlying sTREM2-mediated microglial dysfunction but don’t establish the direct mechanistic link. Understanding this pathway is critical for developing targeted therapeutics that could modulate microglial activation without compromising beneficial functions.
Gap type: unexplained_observation Source paper: Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders. (None, None, PMID:37740498)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:41.223132+00:00”, “resolution_summary”: “Resolved by hypothesis SDA-2026-04-02-gap-tau-prop-20260402003221-H002: TREM2-mediated microglial tau clearance enhancement. Supporting evidence includes debate sess_SDA-2026-04-08-gap-pubmed-20260406-062128-afe67892_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “SDA-2026-04-02-gap-tau-prop-20260402003221-H002”, “title”: “TREM2-mediated microglial tau clearance enhancement”, “score”: 0.232, “reason”: “23 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-04-gap-tau-prop-20260402003221”, “target_gene”: “TREM2”, “target_pathway”: “TREM2/TYROBP microglial signaling”, “disease”: “neurodegeneration”, “composite_score”: 0.780383, “confidence_score”: 0.665, “status”: “proposed”, “pubmed_evidence_ids”: [“24990881”, “28602351”, “28802038”, “31932797”, “33516818”]}, {“id”: “h-trem2-fe8c644a”, “title”: “Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Phagocytosis from Inflammation”, “score”: 0.23, “reason”: “18 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-02-gap-001”, “target_gene”: “TREM2, ADAM10, ADAM17”, “target_pathway”: “ectodomain shedding, microglial survival signaling”, “disease”: “Alzheimer’s disease”, “composite_score”: 0.71429, “confidence_score”: 0.65, “status”: “proposed”, “pubmed_evidence_ids”: [“27986010”, “29695715”, “33483491”, “41509917”]}, {“id”: “h-d5dea85f”, “title”: “Microglial Senescence Prevention via TREM2/SASP Axis”, “score”: 0.229, “reason”: “19 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-150544-e3a2eab9”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.837096, “confidence_score”: 0.48, “status”: “proposed”, “pubmed_evidence_ids”: [“28602351”, “28802038”, “30738892”, “31902528”, “31932797”]}, {“id”: “h-var-59fc393ba6”, “title”: “Microglial-Mediated Tau Clearance Dysfunction via TREM2 Receptor Impairment”, “score”: 0.227, “reason”: “18 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-03-26abc5e5f9f2”, “target_gene”: “MAPT”, “target_pathway”: “TREM2-mediated microglial clearance”, “disease”: “neuroscience”, “composite_score”: 0.739401, “confidence_score”: 0.775, “status”: “proposed”, “pubmed_evidence_ids”: [“31285742”, “40392508”, “40639927”, “40898879”, “41313318”]}, {“id”: “h-aa1f5de5cd”, “title”: “TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switching from protective ‘disease-associated microglia’ to neurotoxic ‘inflammasome-active’ states”, “score”: 0.227, “reason”: “18 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-02-gap-synaptic-pruning-microglia”, “target_gene”: “TREM2, TYROBP (DAP12), APOE”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.7, “confidence_score”: 0.22, “status”: “proposed”, “pubmed_evidence_ids”: [“26598730”, “27753624”, “28602351”, “28802038”, “29070674”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062128-afe67892_task_9aae8fc5”, “title”: “While the study demonstrates both NF-κB pathway activation and increased C1qa expression after prolonged anesthesia, the mechanistic link between neuroinflammation and complement activation remains unclear. This connection is critical for developing targeted interventions.\n\nGap type: unexplained_observation\nSource paper: Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors. (2023, BMC Med, PMID:36600274)”, “score”: 0.631, “reason”: “15 token overlaps; entity overlap: nf-, pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062128-afe67892”, “quality_score”: 0.74, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755_task_9aae8fc5”, “title”: “The study shows SPP1 from perivascular cells drives microglial synaptic engulfment, but the specific receptors, signaling pathways, and molecular cascades linking SPP1 to phagocytic gene expression remain undefined. Understanding this mechanism is critical for developing targeted therapeutics that could modulate pathological synaptic loss.\n\nGap type: unexplained_observation\nSource paper: Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease. (2023, Nat Neurosci, PMID:36747024)”, “score”: 0.496, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755”, “quality_score”: 0.704, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.491, “reason”: “15 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b_20260413-202651”, “title”: “The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity are not detailed. Understanding this tolerance mechanism is critical for developing targeted therapies for neuromyelitis optica.\n\nGap type: unexplained_observation\nSource paper: B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. (2024, Nature, PMID:38383779)”, “score”: 0.483, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b”, “quality_score”: 0.79, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b_20260413-221849”, “title”: “The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity are not detailed. Understanding this tolerance mechanism is critical for developing targeted therapies for neuromyelitis optica.\n\nGap type: unexplained_observation\nSource paper: B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. (2024, Nature, PMID:38383779)”, “score”: 0.483, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b”, “quality_score”: 0.66, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}